Details for New Drug Application (NDA): 087421
✉ Email this page to a colleague
NDA 087421 describes TYLENOL W/ CODEINE NO. 4, which is a drug marketed by Ortho Mcneil Pharm and Janssen Pharms and is included in two NDAs. Additional details are available on the TYLENOL W/ CODEINE NO. 4 profile page.
The generic ingredient in TYLENOL W/ CODEINE NO. 4 is acetaminophen; codeine phosphate. There are sixty-six drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the acetaminophen; codeine phosphate profile page.
The generic ingredient in TYLENOL W/ CODEINE NO. 4 is acetaminophen; codeine phosphate. There are sixty-six drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the acetaminophen; codeine phosphate profile page.
Summary for 087421
| Tradename: | TYLENOL W/ CODEINE NO. 4 |
| Applicant: | Ortho Mcneil Pharm |
| Ingredient: | acetaminophen; codeine phosphate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 300MG;60MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
